Name | Title | Contact Details |
---|---|---|
Jennifer Doherty |
Vice President, Chief Security Officer and Chief Information Officer | Profile |
Jonathan Cos |
Associate Director of Information Security | Profile |
Kevin Burns |
Chief Information Security Officer | Profile |
Curie Co is replacing chemicals with clean, sustainable proteins and enzymes.
ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome – vast stretches of uncharted genetic material that have long been dismissed as “junk DNA.”
Bamboo was formed to advance the work of Dr. Richard Jude Samulski, the Director of the Gene Therapy Center at the University of North Carolina (UNC), from the laboratory into human clinical trials where it could meet the requirements for drug approval. Dr. Samulski is a pioneer in the field of gene therapy. Over thirty (30) years ago, Dr. Samulski was the first person to realize the potential to use the adeno-associated virus (AAV) as a vehicle to replace a defective gene with a healthy gene. Since that time, he has re-engineered the naturally occurring virus to target delivery to certain tissues, de-target other tissues, and improve its safety. This has resulted in over twenty (20) patents related to the use of AAV for therapeutic uses. Dr. Samulski continues to lead innovation in the field of vector optimization and AAV re-engineering.
At Target RWE, we are redefining and revolutionizing the generation and delivery of real-world evidence. Contact us today!
Celula Inc is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.